Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

7.33
-0.2400-3.17%
Post-market: 7.330.00000.00%19:30 EDT
Volume:184.25K
Turnover:1.35M
Market Cap:284.56M
PE:-1.85
High:7.58
Open:7.58
Low:7.12
Close:7.57
52wk High:16.45
52wk Low:5.02
Shares:38.82M
Float Shares:26.88M
Volume Ratio:0.96
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9676
EPS(LYR):-3.4746
ROE:-54.09%
ROA:-29.20%
PB:1.22
PE(LYR):-2.11

Loading ...

Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 24, 2025

Major Issues Report

Form 8-K - Current report